 | • レポートコード：MRC2312MG12349 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、75ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の硫酸サルブタモールエアゾール市場規模と予測を収録しています。・世界の硫酸サルブタモールエアゾール市場：売上、2018年-2023年、2024年-2029年 ・世界の硫酸サルブタモールエアゾール市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の硫酸サルブタモールエアゾール市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「90μg/作動」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 硫酸サルブタモールエアゾールのグローバル主要企業は、GSK、 Cipla、 Glenmark Pharmaceuticals、 Sandoz、 Jewim Pharmaceutical、 Sine Pharmaceutical、 Dexa、 Combivent Respimatなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、硫酸サルブタモールエアゾールのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の硫酸サルブタモールエアゾール市場：タイプ別、2018年-2023年、2024年-2029年 世界の硫酸サルブタモールエアゾール市場：タイプ別市場シェア、2022年 ・90μg/作動、100μg/作動 世界の硫酸サルブタモールエアゾール市場：用途別、2018年-2023年、2024年-2029年 世界の硫酸サルブタモールエアゾール市場：用途別市場シェア、2022年 ・喘息、COPD 世界の硫酸サルブタモールエアゾール市場：地域・国別、2018年-2023年、2024年-2029年 世界の硫酸サルブタモールエアゾール市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における硫酸サルブタモールエアゾールのグローバル売上、2018年-2023年 ・主要企業における硫酸サルブタモールエアゾールのグローバル売上シェア、2022年 ・主要企業における硫酸サルブタモールエアゾールのグローバル販売量、2018年-2023年 ・主要企業における硫酸サルブタモールエアゾールのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 GSK、 Cipla、 Glenmark Pharmaceuticals、 Sandoz、 Jewim Pharmaceutical、 Sine Pharmaceutical、 Dexa、 Combivent Respimat ************************************************************* ・調査・分析レポートの概要 硫酸サルブタモールエアゾール市場の定義 市場セグメント 世界の硫酸サルブタモールエアゾール市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の硫酸サルブタモールエアゾール市場規模 世界の硫酸サルブタモールエアゾール市場規模：2022年 VS 2029年 世界の硫酸サルブタモールエアゾール市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの硫酸サルブタモールエアゾールの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の硫酸サルブタモールエアゾール製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：90μg/作動、100μg/作動 硫酸サルブタモールエアゾールのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：喘息、COPD 硫酸サルブタモールエアゾールの用途別グローバル売上・予測 ・地域別市場分析 地域別硫酸サルブタモールエアゾール市場規模 2022年と2029年 地域別硫酸サルブタモールエアゾール売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） GSK、 Cipla、 Glenmark Pharmaceuticals、 Sandoz、 Jewim Pharmaceutical、 Sine Pharmaceutical、 Dexa、 Combivent Respimat ... |
This research report provides a comprehensive analysis of the Salbutamol Sulphate Aerosol market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Salbutamol Sulphate Aerosol market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Salbutamol Sulphate Aerosol, challenges faced by the industry, and potential opportunities for market players.
The global Salbutamol Sulphate Aerosol market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Salbutamol Sulphate Aerosol market presents opportunities for various stakeholders, including Asthma, COPD. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Salbutamol Sulphate Aerosol market. Additionally, the growing consumer demand present avenues for market expansion.
The global Salbutamol Sulphate Aerosol market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Salbutamol Sulphate Aerosol market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Salbutamol Sulphate Aerosol market.
Market Overview: The report provides a comprehensive overview of the Salbutamol Sulphate Aerosol market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., 90 µg/actuation, 100 µg/actuation), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Salbutamol Sulphate Aerosol market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Salbutamol Sulphate Aerosol market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Salbutamol Sulphate Aerosol market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Salbutamol Sulphate Aerosol market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Salbutamol Sulphate Aerosol market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Salbutamol Sulphate Aerosol market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Salbutamol Sulphate Aerosol, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Salbutamol Sulphate Aerosol market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Salbutamol Sulphate Aerosol market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
90 µg/actuation
100 µg/actuation
Market segment by Application
Asthma
COPD
Global Salbutamol Sulphate Aerosol Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
GSK
Cipla
Glenmark Pharmaceuticals
Sandoz
Jewim Pharmaceutical
Sine Pharmaceutical
Dexa
Combivent Respimat
Outline of Major Chapters:
Chapter 1: Introduces the definition of Salbutamol Sulphate Aerosol, market overview.
Chapter 2: Global Salbutamol Sulphate Aerosol market size in revenue and volume.
Chapter 3: Detailed analysis of Salbutamol Sulphate Aerosol manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Salbutamol Sulphate Aerosol in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Salbutamol Sulphate Aerosol capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Salbutamol Sulphate Aerosol Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Salbutamol Sulphate Aerosol Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Salbutamol Sulphate Aerosol Overall Market Size
2.1 Global Salbutamol Sulphate Aerosol Market Size: 2022 VS 2029
2.2 Global Salbutamol Sulphate Aerosol Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Salbutamol Sulphate Aerosol Sales: 2018-2029
3 Company Landscape
3.1 Top Salbutamol Sulphate Aerosol Players in Global Market
3.2 Top Global Salbutamol Sulphate Aerosol Companies Ranked by Revenue
3.3 Global Salbutamol Sulphate Aerosol Revenue by Companies
3.4 Global Salbutamol Sulphate Aerosol Sales by Companies
3.5 Global Salbutamol Sulphate Aerosol Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Salbutamol Sulphate Aerosol Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Salbutamol Sulphate Aerosol Product Type
3.8 Tier 1, Tier 2 and Tier 3 Salbutamol Sulphate Aerosol Players in Global Market
3.8.1 List of Global Tier 1 Salbutamol Sulphate Aerosol Companies
3.8.2 List of Global Tier 2 and Tier 3 Salbutamol Sulphate Aerosol Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Salbutamol Sulphate Aerosol Market Size Markets, 2022 & 2029
4.1.2 90 µg/actuation
4.1.3 100 µg/actuation
4.2 By Type – Global Salbutamol Sulphate Aerosol Revenue & Forecasts
4.2.1 By Type – Global Salbutamol Sulphate Aerosol Revenue, 2018-2023
4.2.2 By Type – Global Salbutamol Sulphate Aerosol Revenue, 2024-2029
4.2.3 By Type – Global Salbutamol Sulphate Aerosol Revenue Market Share, 2018-2029
4.3 By Type – Global Salbutamol Sulphate Aerosol Sales & Forecasts
4.3.1 By Type – Global Salbutamol Sulphate Aerosol Sales, 2018-2023
4.3.2 By Type – Global Salbutamol Sulphate Aerosol Sales, 2024-2029
4.3.3 By Type – Global Salbutamol Sulphate Aerosol Sales Market Share, 2018-2029
4.4 By Type – Global Salbutamol Sulphate Aerosol Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Salbutamol Sulphate Aerosol Market Size, 2022 & 2029
5.1.2 Asthma
5.1.3 COPD
5.2 By Application – Global Salbutamol Sulphate Aerosol Revenue & Forecasts
5.2.1 By Application – Global Salbutamol Sulphate Aerosol Revenue, 2018-2023
5.2.2 By Application – Global Salbutamol Sulphate Aerosol Revenue, 2024-2029
5.2.3 By Application – Global Salbutamol Sulphate Aerosol Revenue Market Share, 2018-2029
5.3 By Application – Global Salbutamol Sulphate Aerosol Sales & Forecasts
5.3.1 By Application – Global Salbutamol Sulphate Aerosol Sales, 2018-2023
5.3.2 By Application – Global Salbutamol Sulphate Aerosol Sales, 2024-2029
5.3.3 By Application – Global Salbutamol Sulphate Aerosol Sales Market Share, 2018-2029
5.4 By Application – Global Salbutamol Sulphate Aerosol Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Salbutamol Sulphate Aerosol Market Size, 2022 & 2029
6.2 By Region – Global Salbutamol Sulphate Aerosol Revenue & Forecasts
6.2.1 By Region – Global Salbutamol Sulphate Aerosol Revenue, 2018-2023
6.2.2 By Region – Global Salbutamol Sulphate Aerosol Revenue, 2024-2029
6.2.3 By Region – Global Salbutamol Sulphate Aerosol Revenue Market Share, 2018-2029
6.3 By Region – Global Salbutamol Sulphate Aerosol Sales & Forecasts
6.3.1 By Region – Global Salbutamol Sulphate Aerosol Sales, 2018-2023
6.3.2 By Region – Global Salbutamol Sulphate Aerosol Sales, 2024-2029
6.3.3 By Region – Global Salbutamol Sulphate Aerosol Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Salbutamol Sulphate Aerosol Revenue, 2018-2029
6.4.2 By Country – North America Salbutamol Sulphate Aerosol Sales, 2018-2029
6.4.3 US Salbutamol Sulphate Aerosol Market Size, 2018-2029
6.4.4 Canada Salbutamol Sulphate Aerosol Market Size, 2018-2029
6.4.5 Mexico Salbutamol Sulphate Aerosol Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Salbutamol Sulphate Aerosol Revenue, 2018-2029
6.5.2 By Country – Europe Salbutamol Sulphate Aerosol Sales, 2018-2029
6.5.3 Germany Salbutamol Sulphate Aerosol Market Size, 2018-2029
6.5.4 France Salbutamol Sulphate Aerosol Market Size, 2018-2029
6.5.5 U.K. Salbutamol Sulphate Aerosol Market Size, 2018-2029
6.5.6 Italy Salbutamol Sulphate Aerosol Market Size, 2018-2029
6.5.7 Russia Salbutamol Sulphate Aerosol Market Size, 2018-2029
6.5.8 Nordic Countries Salbutamol Sulphate Aerosol Market Size, 2018-2029
6.5.9 Benelux Salbutamol Sulphate Aerosol Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Salbutamol Sulphate Aerosol Revenue, 2018-2029
6.6.2 By Region – Asia Salbutamol Sulphate Aerosol Sales, 2018-2029
6.6.3 China Salbutamol Sulphate Aerosol Market Size, 2018-2029
6.6.4 Japan Salbutamol Sulphate Aerosol Market Size, 2018-2029
6.6.5 South Korea Salbutamol Sulphate Aerosol Market Size, 2018-2029
6.6.6 Southeast Asia Salbutamol Sulphate Aerosol Market Size, 2018-2029
6.6.7 India Salbutamol Sulphate Aerosol Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Salbutamol Sulphate Aerosol Revenue, 2018-2029
6.7.2 By Country – South America Salbutamol Sulphate Aerosol Sales, 2018-2029
6.7.3 Brazil Salbutamol Sulphate Aerosol Market Size, 2018-2029
6.7.4 Argentina Salbutamol Sulphate Aerosol Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Salbutamol Sulphate Aerosol Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Salbutamol Sulphate Aerosol Sales, 2018-2029
6.8.3 Turkey Salbutamol Sulphate Aerosol Market Size, 2018-2029
6.8.4 Israel Salbutamol Sulphate Aerosol Market Size, 2018-2029
6.8.5 Saudi Arabia Salbutamol Sulphate Aerosol Market Size, 2018-2029
6.8.6 UAE Salbutamol Sulphate Aerosol Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 GSK
7.1.1 GSK Company Summary
7.1.2 GSK Business Overview
7.1.3 GSK Salbutamol Sulphate Aerosol Major Product Offerings
7.1.4 GSK Salbutamol Sulphate Aerosol Sales and Revenue in Global (2018-2023)
7.1.5 GSK Key News & Latest Developments
7.2 Cipla
7.2.1 Cipla Company Summary
7.2.2 Cipla Business Overview
7.2.3 Cipla Salbutamol Sulphate Aerosol Major Product Offerings
7.2.4 Cipla Salbutamol Sulphate Aerosol Sales and Revenue in Global (2018-2023)
7.2.5 Cipla Key News & Latest Developments
7.3 Glenmark Pharmaceuticals
7.3.1 Glenmark Pharmaceuticals Company Summary
7.3.2 Glenmark Pharmaceuticals Business Overview
7.3.3 Glenmark Pharmaceuticals Salbutamol Sulphate Aerosol Major Product Offerings
7.3.4 Glenmark Pharmaceuticals Salbutamol Sulphate Aerosol Sales and Revenue in Global (2018-2023)
7.3.5 Glenmark Pharmaceuticals Key News & Latest Developments
7.4 Sandoz
7.4.1 Sandoz Company Summary
7.4.2 Sandoz Business Overview
7.4.3 Sandoz Salbutamol Sulphate Aerosol Major Product Offerings
7.4.4 Sandoz Salbutamol Sulphate Aerosol Sales and Revenue in Global (2018-2023)
7.4.5 Sandoz Key News & Latest Developments
7.5 Jewim Pharmaceutical
7.5.1 Jewim Pharmaceutical Company Summary
7.5.2 Jewim Pharmaceutical Business Overview
7.5.3 Jewim Pharmaceutical Salbutamol Sulphate Aerosol Major Product Offerings
7.5.4 Jewim Pharmaceutical Salbutamol Sulphate Aerosol Sales and Revenue in Global (2018-2023)
7.5.5 Jewim Pharmaceutical Key News & Latest Developments
7.6 Sine Pharmaceutical
7.6.1 Sine Pharmaceutical Company Summary
7.6.2 Sine Pharmaceutical Business Overview
7.6.3 Sine Pharmaceutical Salbutamol Sulphate Aerosol Major Product Offerings
7.6.4 Sine Pharmaceutical Salbutamol Sulphate Aerosol Sales and Revenue in Global (2018-2023)
7.6.5 Sine Pharmaceutical Key News & Latest Developments
7.7 Dexa
7.7.1 Dexa Company Summary
7.7.2 Dexa Business Overview
7.7.3 Dexa Salbutamol Sulphate Aerosol Major Product Offerings
7.7.4 Dexa Salbutamol Sulphate Aerosol Sales and Revenue in Global (2018-2023)
7.7.5 Dexa Key News & Latest Developments
7.8 Combivent Respimat
7.8.1 Combivent Respimat Company Summary
7.8.2 Combivent Respimat Business Overview
7.8.3 Combivent Respimat Salbutamol Sulphate Aerosol Major Product Offerings
7.8.4 Combivent Respimat Salbutamol Sulphate Aerosol Sales and Revenue in Global (2018-2023)
7.8.5 Combivent Respimat Key News & Latest Developments
8 Global Salbutamol Sulphate Aerosol Production Capacity, Analysis
8.1 Global Salbutamol Sulphate Aerosol Production Capacity, 2018-2029
8.2 Salbutamol Sulphate Aerosol Production Capacity of Key Manufacturers in Global Market
8.3 Global Salbutamol Sulphate Aerosol Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Salbutamol Sulphate Aerosol Supply Chain Analysis
10.1 Salbutamol Sulphate Aerosol Industry Value Chain
10.2 Salbutamol Sulphate Aerosol Upstream Market
10.3 Salbutamol Sulphate Aerosol Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Salbutamol Sulphate Aerosol Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
